Skip to content

Clinical trials

Completed Phase 1 Anxiety Disorders trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Anxiety Disorders Phase: Phase 1 Status: Completed Clear all

92 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20023
20045
20051
20068
20074
20089
20095
20108
20113
20122
20132
20141
20152
20166
20171
20183
20195
20204
20214
20225
20233
20242
20254

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed92

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
GlaxoSmithKline17
National Center for Complementary and Integrative Health (NCCIH)3
National Institute of Mental Health (NIMH)3
VA Office of Research and Development3
AstraZeneca2
Massachusetts General Hospital2
Medical University of South Carolina2
Northwestern University2
Sandoz2
University of Houston2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Anxiety Disorders92
Depressive Disorder12
Stress Disorders, Post-Traumatic12
Neoplasms6
Pain6
Major Depressive Disorder5
Substance-Related Disorders4
Mental Disorders3
Mood Disorders3
Alcoholism2

Trials

Showing 1 to 25 of 92. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.